Does RF Microneedling Work? Here’s The Clinical Evidence

Clinical Evidence

If you’re considering adding a radiofrequency microneedling device to your clinic, you’ll have seen plenty of marketing claims. What you actually need is proof: does it work, is it safe, and will your clients see results worth paying for?

A 2025 study published in Boletín SELMQ put the Indiba Reverso, a deep fractional RF microneedling device, through exactly that test.

Instead of relying on photos or opinions, researchers used precise measuring tools to track real changes in the skin across eight common patient concerns. Here’s what clinic owners and aesthetic practitioners need to know before investing in a skin rejuvenation device.

The Technology

How Microneedling Works, In Plain Terms

Radiofrequency microneedling devices like Indiba Reverso use very fine needles to deliver heat energy directly into the skin. This does two things at once:

01 — Controlled Channels

It creates tiny, controlled channels in the skin. These prompt the skin to heal itself, replacing damaged tissue with fresh, new skin cells.

02 — Targeted Heat

It heats the surrounding tissue just enough to trigger repair, stimulating the body’s natural production of collagen and elastin.

A gentler layer of heat also tightens existing collagen in the skin immediately, which is why some clients notice some tightening straight after treatment with RF microneedling, even before the deeper regeneration takes effect over the following weeks.

Because this approach creates channels rather than causing broader damage, there’s less bleeding, healing is faster, and the risk of infection is very low — key considerations for any practitioner evaluating a skin rejuvenation device for daily clinical use.

The Device Studied

The Study

Researchers followed 96 patients, split into eight groups of 12, each treated with the Indiba Reverso RF microneedling device for a specific skin concern.

Every patient received four treatments, spaced three to four weeks apart, and their skin was measured before treatment and again four months after their first session.

Imaging technology and ultrasound were used to evaluate results rather than relying on guesswork.

Indiba Reverso deep fractional radiofrequency microneedling device
Measured Results

Here’s What They Found

96 Patients included
8 Skin concerns assessed
4 Treatments per patient
Skin Concern What Improved Measured Result
Overall skin quality Smoother texture 39.5% smoother
Skin firmness Thicker, firmer skin 23% increase
Facial contouring Firmer definition 32% increase
Fine lines Reduced depth of lines 45.6% reduction
Pigmentation / sun spots Less visible pigment 61.9% reduction
Stretch marks Shallower marks 59.3% reduction
Scars (surgical / injury) Flatter, smoother scars 50.4% reduction
Acne scars Shallower scarring 32% reduction

Every one of these results was statistically meaningful, not just a small or coincidental change.

In plain terms: this radiofrequency microneedling device performed consistently and reliably, and the effect was strong across most concerns and still solid for the harder-to-treat ones like acne scarring.

Clinical Results

Two Results Worth Highlighting

Indiba Reverso before and after forehead treatment result
45.6% Reduction in fine line depth
39.5% Improvement in skin smoothness
61.9% Reduction in pigmentation

The improvement in fine lines (45.6%) and skin smoothness (39.5%) achieved by Indiba Reverso were notably strong compared to a similar RF microneedling device tested in other published research, which achieved smaller improvements of around 11.7% and 13% respectively.

If fine lines and skin texture are a big part of your patient demand, this is a meaningful data point.

The 61.9% improvement in pigmentation is also significant. Pigmentation is notoriously difficult to treat consistently with energy-based devices, so a strong, measurable result here is a real point of difference for a skin rejuvenation device.

Safety Data

Safety Your Patients (and Your Insurance) Will Appreciate

Out of 96 patients, only one experienced a side effect: temporary darkening of the skin, which fully cleared up within three months using a standard skin-brightening cream.

No bleeding, bruising, or scarring complications were reported, and patients across a range of skin tones — from lighter to olive/deeper skin types — were included in the study.

Patient Consultation

Setting the Right Expectations Matters

One honest finding: not every patient walked away thrilled, even though their skin had genuinely improved.

Around 45% of patients reported feeling somewhat unsatisfied, despite the measured results being significant.

Radiofrequency microneedling delivers real, lasting improvement — but it is a gradual, natural-looking change rather than the dramatic, instant result of surgery.

This matters for your clinic’s consultation process. Patients who understand upfront that they’re investing in genuine tissue repair, rather than an instant fix, tend to be far happier with their results, refer more, and come back for further treatments.

Indiba Reverso facial before and after treatment result
For Clinic Owners

What This Means for Your Clinic

For a skin rejuvenation device to earn its place in your treatment menu, it needs to do three things: work, work safely, and work across a wide enough range of concerns to justify the investment.

This study shows Indiba Reverso, as an RF microneedling device, delivering measurable, significant improvement across eight of the most common reasons patients walk through your door.

From fine lines and pigmentation to scarring and stretch marks, the study reported significant improvements alongside an excellent safety record and no downtime beyond a few days.

Discover More

Explore Indiba Reverso

Learn more about the Reverso fractional radiofrequency system or explore the wider Indiba aesthetics range.

Reference: Naranjo García P, López Andrino R, Corral-Baqués MI, Serrano Arjona O. Efficacy of a New Deep Fractional Radiofrequency Device for Skin Resurfacing and Remodeling. Boletín SELMQ. 2025; XV(1):23–40.